User profiles for Daniel Sheinson
Daniel SheinsonStatistical Researcher at Genentech, Inc.; PhD from University of California, Santa Barbara Verified email at pstat.ucsb.edu Cited by 4521 |
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Therapeutic antibodies that block the programmed death-1 (PD-1)–programmed death-ligand
1 (PD-L1) pathway can induce robust and durable responses in patients with various …
1 (PD-L1) pathway can induce robust and durable responses in patients with various …
[HTML][HTML] A cost-effectiveness framework for COVID-19 treatments for hospitalized patients in the United States
D Sheinson, J Dang, A Shah, Y Meng, D Elsea… - Advances in …, 2021 - Springer
Introduction The COVID-19 pandemic is a global crisis impacting population health and the
economy. We describe a cost-effectiveness framework for evaluating acute treatments for …
economy. We describe a cost-effectiveness framework for evaluating acute treatments for …
Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model
…, M Maia, P Horn, O Siddiqui, D Sheinson… - Antimicrobial agents …, 2017 - Am Soc Microbiol
MHAA4549A, a human monoclonal antibody targeting the hemagglutinin stalk region of
influenza A virus (IAV), is being developed as a therapeutic for patients hospitalized with severe …
influenza A virus (IAV), is being developed as a therapeutic for patients hospitalized with severe …
Trends in use of next-generation sequencing in patients with solid tumors by race and ethnicity after implementation of the Medicare national coverage determination
Importance In March 2018, Medicare issued a national coverage determination (NCD) for
next-generation sequencing (NGS) to facilitate access to NGS testing among Medicare …
next-generation sequencing (NGS) to facilitate access to NGS testing among Medicare …
Correlation of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-seropositive donor and CMV-seronegative solid organ transplant …
JM McBride, D Sheinson, J Jiang… - Open forum …, 2019 - academic.oup.com
Background The rate of cytomegalovirus (CMV) viral load increase and peak viral loads are
associated with CMV disease in kidney and liver transplant recipients, but relationships to …
associated with CMV disease in kidney and liver transplant recipients, but relationships to …
Association between Medicare's national coverage determination and utilization of next-generation sequencing
DM Sheinson, WB Wong, C Flores, S Ogale… - JCO Oncology …, 2021 - ascopubs.org
PURPOSE: In 2018, Medicare issued a national coverage determination (NCD) providing
reimbursement for next-generation sequencing (NGS) tests for beneficiaries with advanced or …
reimbursement for next-generation sequencing (NGS) tests for beneficiaries with advanced or …
Impact of immune checkpoint inhibitors on COVID-19 severity in patients with cancer
R Tan, C Yun, A Seetasith, D Sheinson, R Walls… - The …, 2022 - academic.oup.com
Background Amid continued uncertainty about the management of cancer patients during
the pandemic, this study sought to obtain real-world data on the use of immune checkpoint …
the pandemic, this study sought to obtain real-world data on the use of immune checkpoint …
Five-year patterns of diabetic retinopathy progression in US clinical practice
A Moshfeghi, V Garmo, D Sheinson… - Clinical …, 2020 - Taylor & Francis
Purpose To characterize the natural course of diabetic retinopathy (DR) in contemporary
clinical practice. Patients and Methods This was a retrospective analysis of US claims data …
clinical practice. Patients and Methods This was a retrospective analysis of US claims data …
Comparison of the performance of particle filter algorithms applied to tracking of a disease epidemic
We present general methodology for sequential inference in nonlinear stochastic state-space
models to simultaneously estimate dynamic states and fixed parameters. We show that …
models to simultaneously estimate dynamic states and fixed parameters. We show that …
[HTML][HTML] Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder
A Exuzides, D Sheinson, P Sidiropoulos… - Journal of the …, 2021 - Elsevier
Background Neuromyelitis optica spectrum disorder (NMOSD) is associated with various
comorbidities, including non-autoimmune and autoimmune conditions. The burden and cost of …
comorbidities, including non-autoimmune and autoimmune conditions. The burden and cost of …